Royal Bank of Canada Buys 258,914 Shares of Healthpeak Properties, Inc. $DOC

Royal Bank of Canada increased its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 24.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,339,913 shares of the real estate investment trust's stock after buying an additional 258,914 shares during the quarter. Royal Bank of Canada owned 0.19% of Healthpeak Properties worth $27,093,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of DOC. TCTC Holdings LLC lifted its position in shares of Healthpeak Properties by 124.3% during the 1st quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust's stock worth $27,000 after buying an additional 751 shares during the period. Brooklyn Investment Group increased its holdings in Healthpeak Properties by 198.9% during the 1st quarter. Brooklyn Investment Group now owns 1,312 shares of the real estate investment trust's stock valued at $27,000 after purchasing an additional 873 shares in the last quarter. Future Financial Wealth Managment LLC acquired a new stake in Healthpeak Properties during the 1st quarter valued at $30,000. S.A. Mason LLC increased its holdings in Healthpeak Properties by 160.9% during the 1st quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock valued at $30,000 after purchasing an additional 925 shares in the last quarter. Finally, Dagco Inc. acquired a new stake in Healthpeak Properties during the 1st quarter valued at $30,000. Institutional investors own 93.57% of the company's stock.

Healthpeak Properties Trading Down 0.2%

DOC stock traded down $0.04 during midday trading on Friday, reaching $18.10. The stock had a trading volume of 4,343,202 shares, compared to its average volume of 6,111,745. The business has a fifty day simple moving average of $17.76 and a two-hundred day simple moving average of $18.20. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.06. The firm has a market cap of $12.58 billion, a price-to-earnings ratio of 75.44, a PEG ratio of 2.33 and a beta of 1.07. Healthpeak Properties, Inc. has a twelve month low of $16.63 and a twelve month high of $23.26.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting analysts' consensus estimates of $0.46. The firm had revenue of $694.35 million during the quarter, compared to analyst estimates of $697.14 million. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.The company's revenue was down .2% on a year-over-year basis. During the same period last year, the company earned $0.45 earnings per share. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, research analysts expect that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The company also recently disclosed a monthly dividend, which was paid on Friday, August 29th. Investors of record on Monday, August 18th were given a $0.1017 dividend. This represents a c) dividend on an annualized basis and a yield of 6.7%. The ex-dividend date was Monday, August 18th. Healthpeak Properties's dividend payout ratio (DPR) is presently 508.33%.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on DOC shares. Wells Fargo & Company dropped their price target on Healthpeak Properties from $20.00 to $18.00 and set an "equal weight" rating for the company in a report on Wednesday, August 27th. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and set a $18.00 price target (down from $28.00) on shares of Healthpeak Properties in a report on Wednesday, August 20th. Wall Street Zen cut Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Monday, July 7th. Robert W. Baird set a $21.00 price target on Healthpeak Properties and gave the company an "outperform" rating in a report on Wednesday, July 30th. Finally, Scotiabank cut Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and dropped their price target for the company from $21.00 to $19.00 in a report on Tuesday, July 29th. Seven equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $21.50.

Insider Buying and Selling

In other news, CEO Scott M. Brinker acquired 1,490 shares of the stock in a transaction that occurred on Monday, August 4th. The stock was purchased at an average cost of $16.83 per share, for a total transaction of $25,076.70. Following the completion of the transaction, the chief executive officer directly owned 211,906 shares in the company, valued at $3,566,377.98. This trade represents a 0.71% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders bought 8,783 shares of company stock valued at $150,129 in the last three months. 0.23% of the stock is owned by company insiders.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.